Abstract
Trichomoniasis is a parasitic disease that affects the human reproductive and urinary systems, representing a substantial non-viral sexually transmitted infection worldwide. Given its impact on reproductive health, and the limited available information on the prevalence of Trichomonas vaginalis, this study aimed to evaluate the prevalence of T. vaginalis among women referred to health centers in Tabriz, Northwest Iran. Study was conducted on 448 suspicious women who attended to 29Bahman hospital in Tabriz, Northwest Iran, during September 2020 to September 2021. Demographic data were collected according to the study protocol. Vaginal discharges were obtained using sterile swabs, and the prevalence of T. vaginalis was determined using Papanicolauo staining and PCR method. Among the 448 cases studied, 48 (10.7%) samples were suspected as a T. vaginalis infection, while 4 (0.89%) confirmed using the PCR method. The mean age of infected individuals was 41.7 ± 9.4 years. No statistical correlation was observed between inflammation, method of contraception and infection (p = 0.8). The present study revealed a relatively low prevalence of T. vaginalis infection within the study population. Additionally, the utilization of the PCR method can be beneficial in confirming suspected samples.
Keywords: Trichomoniasis, PCR, Papanicolauo stain, Prevalence
Introduction
Trichomoniasis is a parasitic infection caused by the flagellated protozoan Trichomonas vaginalis (T. vaginalis). It is one of the most common non-viral sexually transmitted infections (STIs) worldwide among women and men. While men are often asymptomatic carriers, some may experience dysuria and discharge. In women, the infection varies from asymptomatic to severe and reported during the reproductive years (Newman et al. 2015; Aquino et al. 2020; Zhang et al. 2022). Recent studies have shown that approximately 6.5% of women have asymptomatic infection. However, symptoms include a malodorous, purulent discharge, with the serious symptoms such as infertility, premature rupture of placental membranes, premature delivery, low-birth-weight infants, and neonatal death have been reported (Meites et al. 2015). Furthermore, numerous studies have linked T. vaginalis infection to important and costly health outcomes such as human immunodeficiency virus (HIV). To mitigate the complications of HIV, particularly in regions where T. vaginalis is prevalent, it is essential to control T. vaginalis (Yang et al. 2018; Masha et al. 2019; Rowley et al. 2019; Ebrahimi et al. 2023). The World Health Organization (WHO) estimated 156 million cases of Trichomonas vaginalis infections worldwide, constituting almost half of the total global incidence of STIs among adults aged 15 to 49 years (Rowley et al. 2019). Several studies also have been conducted in Iran and the prevalence rate of infection in different age groups of women reported 0.5% to about 39% (Taghavi et al. 2014; Hezarjaribi et al. 2015; Dehghan Haghighi et al. 2019).
High prevalence of trichomoniasis has been associated with population density, migration to suburban areas with poor socio-economic and cultural conditions, and high-risk behaviours among adolescents (Hezarjaribi et al. 2015; Siyadatpanah et al. 2023). Diagnosing trichomoniasis based solely on symptoms can lead to misdiagnosis, as some individuals may be asymptomatic or their symptoms may be confused with other STDs (Huppert et al. 2007). Hence, laboratory investigation is important for accurate diagnosis and proper treatment of trichomoniasis (Al-Ardi 2021). The diagnosis of T. vaginalis conducted with different methods including wet mount, staining, parasite culture, polymerase chain reaction (PCR), and antigen–antibody rapid screening (Matini et al. 2014; Momeni et al. 2015; Spotin et al. 2016; Van Der Pol 2016). Despite the numerous studies conducted in different regions of Iran, little information about the prevalence of T. vaginalis in northwest of Iran has been reported. The current study aimed to evaluate the prevalence of T. vaginalis among women referred to 29Bahman hospital in Tabriz, Northwest Iran.
Materials and methods
Sample collection
In the present study, 448 vaginal swabs were collected during September 2020 to September 2021 from women showing suspicious signs of T. vaginalis at the 29Bahman Hospital of Tabriz, Northwest Iran (Fig. 1). The swabs were obtained with the aid of a disposable vaginal speculum and sterile swabs. Written consent was provided to each participant for sample collection. Demographic information was self-reported by the participants. All patients provided an informed consent, and the study design was approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (IR.TBZMED.REC.1398.359).
Fig. 1.
Tabriz province location on the map of Iran
Papanicolauo staining and microscopy examination
The collected specimens were transferred to the department of parasitology and examined using a Pap-prep cytology kit (Ilia Tak Kimia Sahand, Iran). A prepared smear was initially fixed, followed by staining according to the Papanicolaou staining procedure. Subsequently, an experienced laboratory technician conducted a microscopic examination, thoroughly scrutinizing the prepared slide (Lara-Torre et al. 2003).
DNA extraction and PCR
The total DNA of T. vaginalis was directly extracted from positive slides using the YTA genomic DNA extraction tissue kit (Cat No. YT9030, YTA, Iran) according to the manufacturer’s instructions. A PCR test was performed using a T. vaginalis-specific primer set (TVK3-TVK7). Each PCR reaction tube contained 5 µl DNA, 1 µl forward primer, 1 µl reverse primer, 10 µl PCR mastermix, and 3 µl DDW. The PCR conditions were as follows: an initiation step at 94˚C for 5 min, followed by 30 cycles at 94˚C for 30 s, 52˚C for 30 s, and 72˚C for 30 s. A final extension step at 72˚C was then conducted for 5 min. The PCR primer set F: 5-ATTGTCGAACATTGGTCTTACCCTC-3 and R: 5-TCTGTGCCGTCTTCAAGTATGC-3 amplified the 261 bp (bp) products. Positive control consisted of DNA extracted from a clinical isolate of T. vaginalis grown in vitro, and negative control included nuclease-free water. Additionally, a 100 kb ladder was used as a size marker (Spotin et al. 2016).
Statistical analysis
Data was recorded and analyzed with the SPSS v.18 software (SPSS Inc., Chicago, ILL, USA) using Mann-Whitney and Chi-square tests. The p value < 0.05 was considered as significant.
Results
Out of the symptomatic women referred to the health center, 48 cases were initially diagnosed with suspected T. vaginalis infection through staining (Fig. 2). The infection was confirmed in 4 cases after utilizing the molecular method (Fig. 3; Table 1). All of the infected individuals were married, with a mean age of 41.7 ± 9.4 years. The findings regarding contraceptive methods indicated that 11.6%, 11.8%, and 6.47% of the subjects used condoms, oral tablets, and intrauterine devices (IUDs), respectively. Additionally, 11.6% of the referred women showed a high rate of inflammation (Table 2). A statistical analysis revealed no significant correlation between inflammation, method of contraception, and parasitological results (p = 0.8).
Fig. 2.
(A) T. vaginalis in direct microscopy 40X in urine sample; (B) T. vaginalis in papanicolauo staining 100X in Pap smear microscopic
Fig. 3.

Agarose gel electrophoresis of TVK3-TVK7 PCR products; Line1 100 bp ladder, Line 2 positive control, line 3 negative control and Line 4–7 amplification product of patients
Table 1.
The results of the methods used in the diagnosis of individuals suspected of T. Vaginalis
| Method | Positive (%) | Negative (%) | Total |
|---|---|---|---|
| Papanicolauo staining | 48 (10.71) | 400 (89.29) | 448 |
| PCR | 4 (0.89) | 444 (99.11) | 448 |
Table 2.
The results of the investigated factors in individuals suspected of T. Vaginalis
| Contraception methods | Inflammation | Factor responsible for inflammation | Age groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| None | Contraceptive drugs | Natural | Condom | IUD | Tubal ligation | None | Mild | Moderate | High | Trichomoniasis | Bacteria | Fungus | None-infectious agent | |
| - | 19 | 94 | 24 | 5 | 2 | 17 | 85 | 77 | 22 | 14 | 63 | 32 | 62 | 23–34 |
| - | 26 | 57 | 27 | 18 | 33 | 22 | 61 | 57 | 17 | 16 | 35 | 49 | 78 | 35–46 |
| 76 | 8 | 29 | 1 | 6 | 23 | 20 | 31 | 26 | 13 | 18 | 32 | 15 | 34 | 47–59 |
Discussion
There are various microbial agents associated with women’s vaginal discharge, with trichomoniasis being the most common sexually transmitted disease (STD) worldwide. The global prevalence of trichomoniasis has been estimated to range between 5% and 74% (Johnston and Mabey 2008; Korycińska et al. 2017). In Iran, in a systematic review and meta-analysis study, the prevalence rate of trichomoniasis in different age groups has been estimated to be between 8% and 38.8% (Hezarjaribi et al. 2015). In the present study, the mean age of infected individuals was 41.7 ± 9.4 years. The age-specific distribution of Trichomonas infection is important, and in the current study, women aged 47–59 years had the highest infection rate. This finding is consistent with the results of several previous studies (Matini et al. 2012; Nazari et al. 2015; Patel et al. 2018). Additionally, factors associated with aging have been suggested to influence older adults’ susceptibility to STIs, potentially due to biological changes in older women serving as predisposing factors for parasite growth (Nazari et al. 2015).
The study conducted by Haghighi et al. in Zahedan, was in line with our study and reported a 23.3% (21/90) infection rate based on wet mount microscopy (Dehghan Haghighi et al. 2019). Ambrozio et al. in Brazil revealed that 9% of patients tested positive for T. Vaginalis infection through direct examination (Ambrozio et al. 2016). In another study in Brazil, the presence of T. vaginalis was identified in 16% of samples using the TYM culture medium (von Glehn et al. 2017). Sutton et al. in the USA, conducted a study on women aged 14–49 years, which found a 3.1% infection rate (Sutton et al. 2007). Additionally, Keşli et al. in Turkey, surveyed the incidence of T. vaginalis in women with vaginal discharge complaints using wet-mount and Giemsa staining methods, and reported a 9% infection rate (Keşli et al. 2012).
In addition, the detection of infection is another important factor affecting the prevalence rate of trichomoniasis, and involves a variety of methods, ranging from clinical diagnosis to laboratory-based techniques. Microscopic examination of a vaginal wet mount is one of the most important methods for diagnosing T. vaginalis infection (Van Der Pol 2016). The sensitivity range of wet mount microscopic examination is estimated to be 44–68%. While the wet mount method is rapid and inexpensive, the quality of this diagnostic test largely depends on the expertise and experience of the person operating the microscope (Hobbs and Seña 2013; Van Der Pol 2016). Liquid-based preparations have been shown to facilitate the diagnosis of T. vaginalis. Women noted to carry the organism are recommended to undergo confirmatory testing. Recent studies have reported that molecular-based techniques such as PCR are highly specific and sensitive, providing more reliable estimates (Ginocchio et al. 2012; Momeni et al. 2015; Schwebke et al. 2018). The results of a study by Blavo-Kouaméet al., were in line with our study and confirmed a higher sensitivity (100%) and specificity (97.40%) of the PCR method compared to the staining method, with 3.61% of the 194 specimens testing positive(Be et al. 2017). In our study, 48 samples that were considered suspicious for infection through Papanicolaou staining were also analyzed using PCR. Molecular amplification revealed that only 4 samples were related to T. vaginalis infection. Therefore, it should be noted that there is a possibility of reporting pseudo-positive cases. This result is consistent with a study conducted by Haghighi et al., in Zahedan, Iran, where it was expected that the molecular method would produce better results (Dehghan Haghighi et al. 2019).
The prevalence of T. vaginalis varies in different studies, which may be attributed to various factors such as socio-demographic characteristics and personal hygiene (Poole and McClelland 2013). According to the Hezarjaribi et al., study, trichomoniasis is more common in central provinces of Iran, with the lowest rates in the eastern provinces, and a mean prevalence rate of 6.9% and 6.7% in the west and north, respectively. It is likely that the low prevalence of trichomoniasis in our study could be due to better access to primary health and diagnostic services, allowing for the early detection of T. vaginalis infections among individuals (Hezarjaribi et al. 2015). The findings regarding contraceptive methods indicate that 11.6%, 11.8%, and 6.47% of the subjects used condoms, oral tablets, and IUDs, respectively. It appears that the majority of cases reported using natural contraceptive methods were women who were preventing pregnancy naturally (Azambakhtiar et al. 2018). The study has several limitations that should be considered. Firstly, the study had a small number of women diagnosed with trichomoniasis, which may limit the generalizability of the findings. Additionally, the study population consisted of individuals who routinely attended STD clinics, which may not accurately represent the entire female population in Iran in terms of their sexual behaviours and knowledge about STDs. Another limitation is the lack of follow-up of patients after trichomoniasis diagnosis, which could have provided valuable information on treatment outcomes and the long-term effects of the infection.
Conclusion
In summary, our study revealed a relatively low prevalence of T. vaginalis infection among the female population in this area. The PCR method proved valuable in confirming the diagnosis of suspected cases. Further studies, incorporating larger clinical sample sizes and utilizing at least two diagnostic methods, are recommended for the accurate diagnosis of T. vaginalis infection.
Acknowledgements
This study was supported by the Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (Grant number 62666 and 63162). We would like to express our gratitude to all the staff of 29Bahman Health Center in Tabriz who helped us in collecting and preparing the samples.
Author contributions
GB carried out the experiment. MHK wrote the manuscript. RA, RN, AS processed the experimental data, performed the analysis. EA conceived the original idea and supervised the project. All authors discussed the results and contributed to the final manuscript.
Funding
This study was supported by the Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (Grant No. 63162).
Declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Gholamreza Barzgar and Ehsan Ahmadpour contributed equally to this work.
Contributor Information
Reza Ahmadi, Email: drrezaahmadi17@gmail.com.
Mohammad Hasan Kohansal, Email: kohansalhasan@gmail.com.
References
- Al-Ardi MH (2021) Anti-parasitic activity of nano Citrullus colocynthis and nano Capparis spinose against Trichomonas Vaginalis in vitro. J Parasit Dis 45(3):845–850 10.1007/s12639-021-01371-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ambrozio CL, Nagel AS, Jeske S, Bragança GCM, Borsuk S, Villela MM (2016) Trichomonas Vaginalis prevalence and risk factors for women in southern Brazil. Rev Inst Med Trop Sao Paulo 58 [DOI] [PMC free article] [PubMed]
- Aquino MFK, Hinderfeld AS, Simoes-Barbosa A )2020 (Trichomonas Vaginalis. Trends Parasitol 36(7):646–647 [DOI] [PubMed]
- Azambakhtiar A, Nikmanesh B, Rezaeian M, Dashti N, Safari F, Zarebavani M (2018) The prevalence of Trichomoniasis in Women referred to clinical centers in South of Tehran, Iran during 2015–2016. Iran J Parasitol 13:108 [PMC free article] [PubMed] [Google Scholar]
- Be BK, Ke A, Yeo A, Ouattara A, Bonouman AI, At O, Ouhon J, Kette HF (2017) P1. 07 contribution of pcr in the biological diagnosis of trichomonas vaginalis infection at institut pasteur of cote divoire. Sex Transm Infect 93:A46 [Google Scholar]
- Dehghan Haghighi J, Jafarimodrek M, Sohrabi S, Azizi H, Hatam-Nahavandi K (2019) Trichomoniasis Prevalence at a Care Center among women with High-Risk behaviors in Zahedan, Iran. Int J High Risk Behav Addict. 8
- Ebrahimi M, Mehdizad N, Yeganeh-Sefidan F, Safarpour H, Pagheh AS, Pouremamali A, Shiralizadeh S, Ghodrati A, Jafari S, Shahrivar F, Heidarzadeh S (2023) Systematic review and meta-analysis of the global prevalence of sexually transmitted infections in people living with HIV and associated risk factors. AIDS reviews 1;25(3) [DOI] [PubMed]
- Ginocchio C, Chapin K, Smith J, Aslanzadeh J, Snook J, Hill C, Gaydos CA (2012) Prevalence of Trichomonas Vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima trichomonas Vaginalis nucleic acid amplification assay. J Clin Microbiol 50:2601–2608 10.1128/JCM.00748-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hezarjaribi HZ, Fakhar M, Shokri A, Teshnizi SH, Sadough A, Taghavi M (2015) Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis. Parasitol Res 114:1291–1300 10.1007/s00436-015-4393-3 [DOI] [PubMed] [Google Scholar]
- Hobbs MM, Seña AC (2013) Modern diagnosis of Trichomonas vaginalis infection. Sex TransmInfect 89(6):434–438 10.1136/sextrans-2013-051057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huppert J, Mortensen J, Reed J, Kahn J, Miller W, Hobbs M (2007) 6: comparison of diagnostic methods for Trichomonas vaginalis. J Adolesc Health 40:S8 10.1016/j.jadohealth.2006.11.026 [DOI] [Google Scholar]
- Johnston VJ, Mabey DC (2008) Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis 21:56–64 10.1097/QCO.0b013e3282f3d999 [DOI] [PubMed] [Google Scholar]
- Keşli R, Pektaş B, Özdemir M, Günenç O, Coşkun E, Baykan M, Baysal B (2012) 18–45 yaş grubu kadınlarda, trichomonas vaginalis ve diğer mikroorganizmaların vajinal akıntı örneklerinden mikroskobik olarak incelenmesi.Turkiye Parazitolojii Dergisi. 36(3):182–184 [DOI] [PubMed]
- Korycińska J, Dzika E, Waśniewski T, Lepczyńska M, Kubiak K (2017) The prevalence of Trichomonas vaginalis infections in the population of Warmińsko-Mazurskie voivodeship (North-Eastern Poland). Przeglad Epidemiol Rev 71:547–554 [PubMed] [Google Scholar]
- Lara-Torre E, Pinkerton JS (2003) Accuracy of detection of trichomonas vaginalis organisms on a liquid-based papanicolaou smear. Am J Obstet Gynecol 188(2):354–356 [DOI] [PubMed]
- Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T (2019) Trichomonas Vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect 95:36–42 10.1136/sextrans-2018-053713 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matini M, Rezaie S, Mohebali M, Maghsood A, Rabiee S, Fallah M, Rezaeian M (2012) Prevalence of trichomonas vaginalis infection in Hamadan city, Western Iran. Iran J Parasitol 7:67 [PMC free article] [PubMed] [Google Scholar]
- Matini M, Rezaie S, Mohebali M, Maghsood A-H, Rabiee S, Fallah M, Rezaeian M (2014) Genetic identification of Trichomonas vaginalis by using the actin gene and molecular based methods. Iran J Parasitol 9:329 [PMC free article] [PubMed] [Google Scholar]
- Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, Secor WE, Sobel JD, Workowski KA (2015) A review of evidence-based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infections. Clin Infect Dis 61:S837–S848 10.1093/cid/civ738 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Momeni Z, Sadraei J, Kazemi B, Dalimi A (2015) Molecular typing of the actin gene of Trichomonas Vaginalis isolates by PCR-RFLP in Iran. Exp Parasitol 159:259–263 10.1016/j.exppara.2015.10.011 [DOI] [PubMed] [Google Scholar]
- Nazari N, Zangeneh M, Moradi F, Bozorgomid A (2015) Prevalence of Trichomoniasis among women in Kermanshah. Iran Iran Red Crescent Med J 17 [DOI] [PMC free article] [PubMed]
- Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE 10:e0143304 10.1371/journal.pone.0143304 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AA (2018) Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis 67:211–217 10.1093/cid/ciy079 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poole DN, McClelland RS (2013) Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 89(6):418–422 10.1136/sextrans-2013-051075 [DOI] [PubMed] [Google Scholar]
- Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N, Taylor MM (2019) Chlamydia, Gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 97(8):548–562P 10.2471/BLT.18.228486 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwebke JR, Gaydos CA, Nyirjesy P, Paradis S, Kodsi S, Cooper CK (2018) Diagnostic performance of a molecular test versus clinician assessment of vaginitis. J Clin Microbiol 56. 10.1128/jcm00252 – 00218 [DOI] [PMC free article] [PubMed]
- Siyadatpanah A, Norouzi R, Mirzaei F, Haghirosadat BF, Nissapatorn V, Mitsuwan W, Nawaz M, Pereira ML, Hosseini SA, Montazeri M (2023) Green synthesis of nano-liposomes containing Bunium persicum and Trachyspermum ammi essential oils against Trichomonas vaginalis. J Microbiol Immunol Infect 56:150–162 10.1016/j.jmii.2022.06.006 [DOI] [PubMed] [Google Scholar]
- Spotin A, Eghtedar ST, Shahbazi A, Salehpour A, Sarafraz S, Shariatzadeh SA, Mahami-Oskouei M (2016) Molecular characterization of Trichomonas vaginalis strains based on identifying their probable variations in asymptomatic patients. Iran J Parasitol 11:507 [PMC free article] [PubMed] [Google Scholar]
- Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L (2007) The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis 45:1319–1326 10.1086/522532 [DOI] [PubMed] [Google Scholar]
- Taghavi M, Fakhar M, Ziaei Hezarjaribi H, Daryani A, Sarvi S (2014) Trichomoniasis: a neglected parasitic disease among women attending teaching hospitals in Sari. J Mazandaran Univ Med Sci 24:84–91 [Google Scholar]
- Van Der Pol B (2016) Clinical and laboratory testing for Trichomonas vaginalis infection. J Clin Microbiol 54:7–12 10.1128/JCM.02025-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- von Glehn MdP, Sá LCEF, da Silva HDF, Machado ER (2017) Prevalence of Trichomonas Vaginalis in women of reproductive age at a family health clinic. J Infect Dev Ctries 11:269–276 10.3855/jidc.8143 [DOI] [PubMed] [Google Scholar]
- Yang S, Zhao W, Wang H, Wang Y, Li J, Wu X (2018) Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 228:166–173 10.1016/j.ejogrb.2018.06.031 [DOI] [PubMed] [Google Scholar]
- Zhang Z, Li Y, Lu H, Li D, Zhang R, Xie X, Guo L, Hao L, Tian X, Yang Z, Wang S, Mei X (2022) A systematic review of the correlation between Trichomonas vaginalis infection and infertility. Acta Trop 236:106693 [DOI] [PubMed]


